相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。YAP and endothelin-1 signaling: an emerging alliance in cancer
Piera Tocci et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
The role of the Hippo pathway in the pathogenesis of inflammatory bowel disease
Zhuo Xie et al.
CELL DEATH & DISEASE (2021)
Recent Advances of the Hippo/YAP Signaling Pathway in Brain Development and Glioma
Taohui Ouyang et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2020)
Onco-cardiology: Drug-drug interactions of antineoplastic and cardiovascular drugs
Muge Akbulut et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)
USP47-mediated deubiquitination and stabilization of YAP contributes to the progression of colorectal cancer
Beiqing Pan et al.
PROTEIN & CELL (2020)
Multiple roles and context-specific mechanisms underlying YAP and TAZ-mediated resistance to anti-cancer therapy
Francesca Reggiani et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
The role of cardio-protective agents in cardio-preservation in breast cancer patients receiving Anthracyclines ± Trastuzumab: a Meta-analysis of clinical studies
Hagar Elghazawy et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)
LATS1-Beclin1 mediates a non-canonical connection between the Hippo pathway and autophagy
Fengyuan Tang et al.
MOLECULAR & CELLULAR ONCOLOGY (2020)
TEAD1 (TEA Domain Transcription Factor 1) Promotes Smooth Muscle Cell Proliferation Through Upregulating SLC1A5 (Solute Carrier Family 1 Member 5)-Mediated Glutamine Uptake
Islam Osman et al.
CIRCULATION RESEARCH (2019)
Molecular mechanisms of arrhythmogenic cardiomyopathy
Karyn M. Austin et al.
NATURE REVIEWS CARDIOLOGY (2019)
Cell contact and Nf2/Merlin-dependent regulation of TEAD palmitoylation and activity
Nam-Gyun Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Role of YAP/TAZ in Energy Metabolism in the Heart
Toshihide Kashihara et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2019)
The Hippo Signaling Pathway in Cardiac Development and Diseases
Masum M. Mia et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Atheroprotective effects of methotrexate via the inhibition of YAP/TAZ under disturbed flow
Dandan Liu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Hippo Deficiency Leads to Cardiac Dysfunction Accompanied by Cardiomyocyte Dedifferentiation During Pressure Overload
Shohei Ikeda et al.
CIRCULATION RESEARCH (2019)
DLG5 suppresses breast cancer stem cell-like characteristics to restore tamoxifen sensitivity by inhibiting TAZ expression
Jie Liu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Hippo Pathway in Cancer: Aberrant Regulation and Therapeutic Opportunities
Philamer C. Calses et al.
TRENDS IN CANCER (2019)
Yes-Associated Protein (YAP) Facilitates Pressure Overload-Induced Dysfunction in the Diabetic Heart
Shohei Ikeda et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2019)
YAP and TAZ: a signalling hub of the tumour microenvironment
Francesca Zanconato et al.
NATURE REVIEWS CANCER (2019)
Beyond the Cardiomyocyte Consideration of HIPPO Pathway Cell-Type Specificity
Dominic P. Del Re
CIRCULATION RESEARCH (2018)
Hippo Signaling Plays an Essential Role in Cell State Transitions during Cardiac Fibroblast Development
Yang Xiao et al.
DEVELOPMENTAL CELL (2018)
The Hippo pathway in normal development and cancer
Marcello Maugeri-Sacca et al.
PHARMACOLOGY & THERAPEUTICS (2018)
YAP and TAZ in Lung Cancer: Oncogenic Role and Clinical Targeting
Federica Lo Sardo et al.
CANCERS (2018)
Interplay between YAP/TAZ and Metabolism
Ja Hyun Koo et al.
CELL METABOLISM (2018)
Hippo pathway inhibition by blocking the YAP/TAZ-TEAD interface: a patent review
James J. Crawford et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2018)
Discovery of a Small Molecule to Increase Cardiomyocytes and Protect the Heart After Ischemic Injury
Hironori Hara et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2018)
Arterial Wall Stress Induces Phenotypic Switching of Arterial Smooth Muscle Cells in Vascular Remodeling by Activating the YAP/TAZ Signaling Pathway
Yongshun Wang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
MCM7 and its hosted miR-25, 93 and 106b cluster elicit YAP/TAZ oncogenic activity in lung cancer
Federica Lo Sardo et al.
CARCINOGENESIS (2017)
Hippo signalling governs cytosolic nucleic acid sensing through YAP/TAZ-mediated TBK1 blockade
Qian Zhang et al.
NATURE CELL BIOLOGY (2017)
Inhibition of YAP function overcomes BRAF inhibitor resistance in melanoma cancer stem cells
Matthew L. Fisher et al.
ONCOTARGET (2017)
The Hippo pathway in tissue homeostasis and regeneration
Yu Wang et al.
PROTEIN & CELL (2017)
YAP-Dependent AXL Overexpression Mediates Resistance to EGFR Inhibitors in NSCLC
Elena Ghiso et al.
NEOPLASIA (2017)
Verteporfin-induced formation of protein cross-linked oligomers and high molecular weight complexes is mediated by light and leads to cell toxicity
Eleni K. Konstantinou et al.
SCIENTIFIC REPORTS (2017)
Cardiac Tumors: Clinical Perspective and Therapeutic Considerations
Dylan Y. Ren et al.
CURRENT DRUG TARGETS (2017)
The Hippo pathway in organ development, homeostasis, and regeneration
Vivian Fu et al.
CURRENT OPINION IN CELL BIOLOGY (2017)
Hippo pathway effector YAP inhibition restores the sensitivity of EGFR-TKI in lung adenocarcinoma having primary or acquired EGFR-TKI resistance
Jeong Eun Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Hippo pathway and breast cancer stem cells
Marcello Maugeri-Sacca et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
YAP/TAZ as therapeutic targets in cancer
Francesca Zanconato et al.
CURRENT OPINION IN PHARMACOLOGY (2016)
The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation
Yael Aylon et al.
GENES & DEVELOPMENT (2016)
Mechanisms of Hippo pathway regulation
Zhipeng Meng et al.
GENES & DEVELOPMENT (2016)
Onco-cardiology: Present and future
Daisuke Sueta et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
The Hippo pathway mediates inhibition of vascular smooth muscle cell proliferation by cAMP
Tomomi E. Kimura et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
The 2015 WHO Classification of Tumors of the Heart and Pericardium
Allen Burke et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Characterization of Hippo Pathway Components by Gene Inactivation
Steven W. Plouffe et al.
MOLECULAR CELL (2016)
Autopalmitoylation of TEAD proteins regulates transcriptional output of the Hippo pathway
PuiYee Chan et al.
NATURE CHEMICAL BIOLOGY (2016)
The Hippo transducer TAZ promotes cell proliferation and tumor formation of glioblastoma cells through EGFR pathway
Rui Yang et al.
ONCOTARGET (2016)
Hippo Pathway Regulation of Gastrointestinal Tissues
Fa-Xing Yu et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 77 (2015)
The Hippo Pathway in Heart Development, Regeneration, and Diseases
Qi Zhou et al.
CIRCULATION RESEARCH (2015)
miR-206 Mediates YAP-Induced Cardiac Hypertrophy and Survival
Yanfei Yang et al.
CIRCULATION RESEARCH (2015)
Targeting Hippo pathway by specific interruption of YAP-TEAD interaction using cyclic YAP-like peptides
Zheng Zhou et al.
FASEB JOURNAL (2015)
The role of Hippo signal transduction pathway in the development of hypertrophic cardiomyopathy
Wenjian Jiang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Microenvironment rigidity modulates responses to the HER2 receptor tyrosine kinase inhibitor lapatinib via YAP and TAZ transcription factors
Chun-Han Lin et al.
MOLECULAR BIOLOGY OF THE CELL (2015)
The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies
Luping Lin et al.
NATURE GENETICS (2015)
TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells
M. Bartucci et al.
ONCOGENE (2015)
Hippo Pathway Effectors Control Cardiac Progenitor Cell Fate by Acting as Dynamic Sensors of Substrate Mechanics and Nanostructure
Diogo Mosqueira et al.
ACS NANO (2014)
The alteration of Hippo/YAP signaling in the development of hypertrophic cardiomyopathy
Pei Wang et al.
BASIC RESEARCH IN CARDIOLOGY (2014)
A Peptide Mimicking VGLL4 Function Acts as a YAP Antagonist Therapy against Gastric Cancer
Shi Jiao et al.
CANCER CELL (2014)
The Hippo Pathway Is Activated and Is a Causal Mechanism for Adipogenesis in Arrhythmogenic Cardiomyopathy
Suet Nee Chen et al.
CIRCULATION RESEARCH (2014)
An Integrative Analysis of the Tumorigenic Role of TAZ in Human Non-Small Cell Lung Cancer
Satoshi Noguchi et al.
CLINICAL CANCER RESEARCH (2014)
Tumor-propagating cells and Yap/Taz activity contribute to lung tumor progression and metastasis
Allison N. Lau et al.
EMBO JOURNAL (2014)
Metabolic control of YAP and TAZ by the mevalonate pathway
Giovanni Sorrentino et al.
NATURE CELL BIOLOGY (2014)
Cardiac Metabolism and its Interactions With Contraction, Growth, and Survival of Cardiomyocytes
Stephen C. Kolwicz et al.
CIRCULATION RESEARCH (2013)
The p130 Isoform of Angiomotin Is Required for Yap-Mediated Hepatic Epithelial Cell Proliferation and Tumorigenesis
Chunling Yi et al.
SCIENCE SIGNALING (2013)
Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
Yi Liu-Chittenden et al.
GENES & DEVELOPMENT (2012)
Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis
Bin Zhao et al.
GENES & DEVELOPMENT (2012)
YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy
Alexander von Gise et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Branched-chain amino acid metabolism in heart disease: an epiphenomenon or a real culprit?
Ying Huang et al.
CARDIOVASCULAR RESEARCH (2011)
Not Too Large and Not Too Small-Just the Right Size: A Hippo-Sized Heart
Edward E. Morrisey
CIRCULATION RESEARCH (2011)
Hippo pathway regulation by cell morphology and stress fibers
Ken-Ichi Wada et al.
DEVELOPMENT (2011)
Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein
Bin Zhao et al.
GENES & DEVELOPMENT (2011)
Role of YAP/TAZ in mechanotransduction
Sirio Dupont et al.
NATURE (2011)
The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal
Bin Zhao et al.
NATURE CELL BIOLOGY (2011)
Hippo Pathway Inhibits Wnt Signaling to Restrain Cardiomyocyte Proliferation and Heart Size
Todd Heallen et al.
SCIENCE (2011)
Regulation of Insulin-Like Growth Factor Signaling by Yap Governs Cardiomyocyte Proliferation and Embryonic Heart Size
Mei Xin et al.
SCIENCE SIGNALING (2011)
The Hippo Signaling Pathway in Development and Cancer
Duojia Pan
DEVELOPMENTAL CELL (2010)
Anti-endothelin drugs in solid tumors
Antonio Russo et al.
EXPERT OPINION ON EMERGING DRUGS (2010)
A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF beta-TRCP
Bin Zhao et al.
GENES & DEVELOPMENT (2010)
YAP1 increases organ size and expands undifferentiated progenitor cells
Fernando D. Camargo et al.
CURRENT BIOLOGY (2007)
Elucidation of a universal size-control mechanism in Drosophila and mammals
Jixin Dong et al.
CELL (2007)
From cell structure to transcription: Hippo forges a new path
BA Edgar
CELL (2006)
The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA damage
S Strano et al.
MOLECULAR CELL (2005)
Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis
S Basu et al.
MOLECULAR CELL (2003)
分享论文
